However, recent studies using Sox9 chromatin immunoprecipitation (ChIP) combined with deep sequencing (ChIP-seq) analysis have reported that Sox9 can activate canonical Wnt/β-catenin signaling in hepatocellular carcinoma [9] and prostate cancer [10]. This evidence concerns the gene SOX9 and prostate cancer.